Enovis (ENOV) Operating Income (QoQ) (2010 - 2026)
Enovis (ENOV) Operating Income (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn |
| 10 | Enovis | 1.59 Bn | 1.56 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 101.30% |
| Dec 31, 2025 | 10.08% |
| Oct 3, 2025 | -3,225.13% |
| Jul 4, 2025 | 64.09% |
| Apr 4, 2025 | 92.96% |
| Dec 31, 2024 | -1,994.56% |
| Sep 27, 2024 | 28.23% |
| Jun 28, 2024 | -26.29% |
| Mar 29, 2024 | -508.41% |
| Dec 31, 2023 | 71.92% |
| Sep 29, 2023 | -41.38% |
| Jun 30, 2023 | 41.95% |
| Mar 31, 2023 | 11.41% |
| Dec 31, 2022 | -57.29% |
| Sep 30, 2022 | -422.69% |
| Jul 1, 2022 | 118.13% |
| Apr 1, 2022 | -68.19% |
| Dec 31, 2021 | -13.06% |
| Oct 1, 2021 | -55.61% |
| Jul 2, 2021 | -116.88% |